Dr. Raghib Ali
FRCP MA(cantab) MA(oxon)
Raghib Ali is a Clinical Epidemiologist in the Cancer Epidemiology Unit, an Honorary Consultant in Acute Medicine at the John Radcliffe Hospital and Director of the INDOX Cancer Research Network. His main research interests are the aetiology, prevention & treatment of non-communicable diseases in Middle Eastern and South Asian populations. He is the principal investigator for a number of clinical trials and epidemiological studies including a case-control study of colorectal cancer in India looking at the association between life-long vegetarianism and colorectal cancer in India; a prospective cohort study investigating risk factors for diabetes in the UAE and a number of studies comparing the incidence of cancer in different ethnic groups in the UK.
He graduated in Medicine from Cambridge University in 1999 where he was awarded the John Addenbrooke’s prize for Medicine and also has postgraduate degrees from the Universities of Oxford and London. He completed his clinical training in General (Internal) Medicine and Clinical Pharmacology from the Oxford Deanery in 2009.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Mokdad AH. et al, (2016), The Lancet. Global health
Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis.
Maruthappu M. et al, (2016), Lancet, 388, 684 - 695
Perceptions and Attitudes towards Medical Research in the United Arab Emirates: Results from the Abu Dhabi Cohort Study (ADCS) Focus Group Discussions
El Obaid Y. et al, (2016), PLOS ONE, 11, e0149609 - e0149609
Midwakh/dokha tobacco use in the Middle East: much to learn.
Vupputuri S. et al, (2016), Tob Control, 25, 236 - 241
Trends in UK regional cancer mortality 1991-2007.
Marshall DC. et al, (2016), Br J Cancer, 114, 340 - 347